Impact of the severity of end-stage liver disease in cardiac structure and function



Título del documento: Impact of the severity of end-stage liver disease in cardiac structure and function
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000418097
ISSN: 1665-2681
Autores: 1
1
1
1
1
1
1
1
1
1
1
Instituciones: 1Universidade de Sao Paulo, Faculdade de Medicina, Sao Paulo. Brasil
Año:
Periodo: Feb
Volumen: 12
Paginación: 85-91
País: México
Idioma: Inglés
Tipo de documento: Estadística o encuesta
Enfoque: Analítico
Resumen en inglés The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. Material and methods. 184 patients underwent a protocol providing data on the severity of ESLD and undergoing echocardiography to assess the diameters of the left atrium and right ventricle; the systolic and diastolic diameters of the left ventricle, interventricular septum, and posterior wall of the left ventricle; systolic pulmonary artery pressure; ejection fraction; and diastolic function. Severity of ESLD was assessed by the Model for End-Stage Liver Disease (MELD) score. Results. Left-atrial diameter (r = 0.323; IC 95% 0.190-0.455; p < 0.001), left-ventricular diastolic diameter (r = 0.177; IC 95% 0.033-0.320; p = 0.01) and systolic pulmonary artery pressure (r = 0.185; IC 95% 0.036-0.335; p = 0.02) significantly correlated with MELD score. Patients with MELD ≥ 16 had significantly higher left-atrial diameter and systolic pulmonary artery pressure, compared with patients with MELD scores < 16 points. Conclusions. Changes in cardiac structure and function correlate with the severity of ESLD
Disciplinas: Medicina
Palabras clave: Gastroenterología,
Sistema cardiovascular,
Cirrosis,
Remodelación cardiaca,
Trasplantes,
Hígado,
Cardiomiopatia cirrótica,
Enfermedad hepática terminal
Keyword: Gastroenterology,
Cardiovascular system,
Cirrhosis,
Cardiac remodelling,
Transplantation,
Liver,
Cirrhotic cardiomyopathy,
End-stage liver disease
Texto completo: Texto completo (Ver PDF)